- Home
- OSW vs CGON Comparison
OSW vs CGON Comparison
Compare OSW & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSW
- CGON
- Stock Information
- Founded
- OSW N/A
- CGON 2010
- Country
- OSW Bahamas
- CGON United States
- Employees
- OSW N/A
- CGON N/A
- Industry
- OSW Hotels/Resorts
- CGON
- Sector
- OSW Consumer Discretionary
- CGON
- Exchange
- OSW Nasdaq
- CGON NYSE
- Market Cap
- OSW 2.1B
- CGON 2.4B
- IPO Year
- OSW N/A
- CGON 2024
- Fundamental
- Price
- OSW $20.18
- CGON $28.67
- Analyst Decision
- OSW Strong Buy
- CGON Strong Buy
- Analyst Count
- OSW 4
- CGON 8
- Target Price
- OSW $20.00
- CGON $63.88
- AVG Volume (30 Days)
- OSW 535.8K
- CGON 932.1K
- Earning Date
- OSW 10-30-2024
- CGON 02-02-2025
- Dividend Yield
- OSW 0.40%
- CGON N/A
- EPS Growth
- OSW 2284.58
- CGON N/A
- EPS
- OSW 0.50
- CGON N/A
- Revenue
- OSW $872,619,000.00
- CGON $684,000.00
- Revenue This Year
- OSW $13.42
- CGON $162.50
- Revenue Next Year
- OSW $8.66
- CGON $17.62
- P/E Ratio
- OSW $40.60
- CGON N/A
- Revenue Growth
- OSW 13.60
- CGON 258.12
- 52 Week Low
- OSW $11.98
- CGON $25.77
- 52 Week High
- OSW $20.57
- CGON $50.23
- Technical
- Relative Strength Index (RSI)
- OSW 60.32
- CGON 34.14
- Support Level
- OSW $19.37
- CGON $27.00
- Resistance Level
- OSW $20.56
- CGON $30.00
- Average True Range (ATR)
- OSW 0.57
- CGON 2.03
- MACD
- OSW -0.05
- CGON -0.42
- Stochastic Oscillator
- OSW 74.34
- CGON 17.16
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts worldwide. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.